Celsius Holdings Inc. (NASDAQ:CELH) Stock Has Average Target Price of $41.53 According to Brokerages

Key Points

• Analysts maintain a “Moderate Buy” consensus on Celsius, with 14 buy, six hold and one sell rating; the average 12-month price target is $41.53 versus a recent share price of $29.12.
• Celsius’s latest quarter fell short of expectations, reporting $0.36 in earnings per share versus $0.41 expected and revenue of $817.93 million versus $870.08 million forecast. Analysts expect earnings to decline in the upcoming quarter, with results scheduled for November 5.
• Legal risks are increasing: Celsius faces an investor securities lawsuit and a separate consumer lawsuit alleging misleading “health-washing” claims, potentially affecting its finances, reputation and marketing practices.

Shares of Celsius Holdings Inc. (NASDAQ:CELH - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twenty-one ratings firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $41.53.

Several equities analysts recently weighed in on CELH shares. UBS Group set a $38.00 price objective on shares of Celsius in a research report on Thursday, October 15th. Stifel Nicolaus set a $37.00 price objective on shares of Celsius in a report on Friday, August 7th. TD Cowen decreased their price objective on shares of Celsius from $41.00 to $35.00 and set a "buy" rating for the company in a report on Tuesday, October 13th. The Goldman Sachs Group set a $45.00 target price on shares of Celsius in a research report on Monday, August 10th. Finally, Piper Sandler restated an "overweight" rating and set a $36.00 target price on shares of Celsius in a report on Monday, August 24th.

Celsius Stock Performance

Shares of NASDAQ CELH opened at $29.12 on Friday. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.80 and a quick ratio of 1.42. Celsius has a one year low of $23.56 and a one year high of $61.49. The business's 50-day moving average price is $29.13 and its two-hundred day moving average price is $34.71. The company has a market capitalization of $7.37 billion, a P/E ratio of 121.33, a price-to-earnings-growth ratio of 2.03 and a beta of 1.01.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.36 earnings per share for the quarter, missing analysts' consensus estimates of $0.41 by ($0.05). The firm had revenue of $817.93 million for the quarter, compared to analysts' expectations of $870.08 million. Celsius had a return on equity of 36.52% and a net margin of 4.24%. The firm's revenue for the quarter was up 10.6% on a year-over-year basis. During the same period last year, the business earned $0.47 earnings per share. Analysts anticipate that Celsius will post 1.42 earnings per share for the current fiscal year.

Insider Transactions at Celsius

In related news, Director Hal Kravitz acquired 12,000 shares of the business's stock in a transaction that occurred on Tuesday, September 15th. The shares were acquired at an average cost of $28.00 per share, with a total value of $336,000.00. Following the purchase, the director owned 239,158 shares of the company's stock, valued at approximately $6,696,424. The trade was a 5.28% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John Fieldly acquired 18,000 shares of the business's stock in a transaction that occurred on Thursday, September 10th. The stock was bought at an average cost of $27.44 per share, for a total transaction of $493,920.00. Following the completion of the purchase, the chief executive officer directly owned 956,063 shares in the company, valued at $26,234,368.72. This represents a 1.92% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders purchased 66,000 shares of company stock worth $1,830,120. 2.33% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Celsius

A number of large investors have recently added to or reduced their stakes in the stock. Ranger Investment Management L.P. bought a new position in Celsius in the 2nd quarter worth approximately $13,629,000. Maven Securities LTD bought a new stake in shares of Celsius in the second quarter valued at approximately $1,192,000. Fifth Third Bancorp boosted its position in shares of Celsius by 4,648.1% in the first quarter. Fifth Third Bancorp now owns 92,873 shares of the company's stock valued at $3,295,000 after acquiring an additional 90,917 shares during the period. Sovran Advisors LLC bought a new stake in shares of Celsius in the first quarter valued at approximately $1,895,000. Finally, Bank of America Corp DE grew its stake in shares of Celsius by 29.2% in the second quarter. Bank of America Corp DE now owns 656,684 shares of the company's stock worth $19,228,000 after acquiring an additional 148,432 shares during the last quarter. Institutional investors own 60.95% of the company's stock.

Celsius News Roundup

Here are the key news stories impacting Celsius this week:

• Neutral Sentiment: Celsius announced that it will release its third-quarter 2026 results before the market opens on Thursday, November 5. The report and management’s outlook will be the next major catalysts for CELH. Celsius Holdings to Release Third Quarter Results
• Negative Sentiment: Multiple investor-rights firms are promoting a securities class action against Celsius and certain officers. The lawsuit covers investors who purchased CELH securities from February 21, 2025, through June 3, 2026, and alleges violations of federal securities laws. The November 3 deadline to seek lead-plaintiff status increases near-term attention on the litigation and creates potential financial, legal and reputational risks. The allegations have not been proven. Celsius Investor Class Action Filed
• Negative Sentiment: A separate federal consumer lawsuit accuses Celsius of “health-washing,” alleging that the company misleadingly marketed its drinks as accelerating metabolism and burning fat. If the claims gain traction, the case could affect brand reputation, marketing practices and potential costs. Celsius has not been found liable based on the reported allegations. Celsius Health-Washing Lawsuit
• Negative Sentiment: Analysts expect Celsius’s third-quarter earnings to decline, while a Zacks preview indicates the company may lack the factors typically associated with an earnings beat. This adds pressure ahead of the November 5 report, particularly after the company’s latest reported quarter missed consensus revenue and EPS estimates. Celsius Q3 Earnings Preview

Celsius Company Profile

Celsius Holdings, Inc NASDAQ: CELH develops, markets and distributes functional beverages designed to support active lifestyles. Its flagship CELSIUS brand offers carbonated and non-carbonated energy drinks, including products positioned around energy, fitness and wellness. The company also markets CELSIUS Essentials, CELSIUS Vibe and powdered drink mixes, with product formulations that commonly feature ingredients such as caffeine, vitamins and other functional components.

Founded in 2004, Celsius has expanded from a niche fitness beverage business into a broader energy-drink platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.